Health Care & Life Sciences » Pharmaceuticals | Taisho Pharmaceutical Holdings Co. Ltd.

Taisho Pharmaceutical Holdings Co. Ltd.

Taisho Pharmaceutical Holdings Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY608.2
Market Cap
JPY653.14 B
Shares Outstanding
85.14 M
Public Float
30.15 M

Profile

Address
3-24-1 Takada
Tokyo Tokyo 170
Japan
Employees -
Website http://www.taisho-holdings.co.jp
Updated 07/08/2019
Taisho Pharmaceutical Holdings Co. Ltd. engages in the management and administration of its group companies that manufactures and sells over-the-counter (OTC) drugs, foods, and other goods, etc. It operates through the following segments: Self-Medication and Prescription Pharmaceutical. The Self-Medication segment conducts research and development (R&D), manufacturing and sale of over-the-counter drugs, quasi-drugs, food, and general medical and hygiene supplies.

Financials

View All
Created with Highcharts 5.0.14Taisho Pharmaceutical Holdings Co. Ltd.Net Income. Fiscal year is April-March. All values JPY Millions.32 69232 69224 52824 52822 47322 47328 78128 78131 67931 67948 59448 594201420152016201720182019010k20k30k40k50k60k
Created with Highcharts 5.0.14Taisho Pharmaceutical Holdings Co. Ltd.Sales/Revenue. Fiscal year is April-March. All values JPY Millions.295 969295 969290 489290 489289 956289 956279 750279 750280 138280 138261 369261 369201420152016201720182019050k100k150k200k250k300k350k

Akira Uehara
President & Representative Director
Ken Uehara
Director, Head-Audit, Finance & Legal Affairs